CJ Godfrey, Ph.D.
Vice President, Strategic Business Development
CJ has 18 years of drug development experience in both pharma and consulting roles and has been applying pharmacometric methods to PK/PD/outcome analysis and decision support for 22 years. His clinical experience spans a broad range of biomarker, safety, and efficacy endpoints with particular emphasis on oncology, rare diseases, inflammation, and viral diseases. He has extensive experience in performing model-based meta-analyses and near-real-time population PK/PD modeling to support informed and timely decision making.